Retinylamine

ID: ALA4566718

Cas Number: 43219-27-8

PubChem CID: 444596

Max Phase: Preclinical

Molecular Formula: C20H31N

Molecular Weight: 285.48

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CN)C(C)(C)CCC1

Standard InChI:  InChI=1S/C20H31N/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13H,7,10,14-15,21H2,1-5H3/b9-6+,12-11+,16-8+,17-13+

Standard InChI Key:  ILYSIVSSNXQZQG-OVSJKPMPSA-N

Molfile:  

 
     RDKit          2D

 21 21  0  0  0  0  0  0  0  0999 V2000
    2.5262  -12.4646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6387  -10.5022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8137  -10.5022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9509  -11.2397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3760  -11.6396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9509  -10.4147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2345  -12.8729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2342  -11.6521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3758  -11.2397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0968  -10.4022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5262  -11.6396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6636  -11.2271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0883  -11.6604    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8009  -11.6480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9470  -11.6396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6636  -12.8771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2345  -11.2230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5218  -11.2355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9470  -12.4646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0885  -11.2271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6634  -11.6521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 17 15  1  0
 11 17  1  0
 19 15  2  0
 10 20  1  0
  9 21  1  0
  1  7  1  0
 13  9  1  0
 12 15  1  0
 21  4  2  0
  3 17  1  0
  8 18  2  0
 16 19  1  0
  2 17  1  0
 18 14  1  0
 14 20  2  0
  5 12  2  0
  1 11  1  0
  4  8  1  0
  7 19  1  0
  6  4  1  0
 20  5  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4566718

    Retinylamine

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPE65 Retinoid isomerohydrolase (75 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LRAT Lecithin retinol acyltransferase (88 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 285.48Molecular Weight (Monoisotopic): 285.2456AlogP: 5.48#Rotatable Bonds: 5
Polar Surface Area: 26.02Molecular Species: BASEHBA: 1HBD: 1
#RO5 Violations: 1HBA (Lipinski): 1HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.64CX LogP: 4.59CX LogD: 2.41
Aromatic Rings: Heavy Atoms: 21QED Weighted: 0.67Np Likeness Score: 2.23

References

1.  (2017)  Compounds and methods of treating ocular disorders, 

Source